Previous CRC studies showed that knockdown of Oct4 would reduce invasiveness (to the liver in a mouse model), survival (in vitro), and CSC marker expression, as well as promote apoptosis in colorectal cancer cell lines [40, 41]. This evidence concerns the gene POU5F1 and colorectal carcinoma.